Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (758,088) $ (1,341,036)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation expense 1,523 1,715  
Amortization expense 900  
Stock based compensation 37,500 37,500  
Accretion of debt discount 43,207 791,708  
Accretion of original issuance costs 83,399 42,737  
Modification of warrants (15,806)  
Changes in operating assets and liabilities:      
Other current assets 4,783 (28,219)  
Accounts payable 67,804 (62,432)  
Accrued payroll and payroll taxes 285,908 11,000  
Other current liabilities (1,648) (640)  
Net cash used in operating activities (235,612) (562,573)  
Cash flows from investing activities:      
Net cash used in investing activities  
Cash flows from financing activities:      
Proceeds from short-term convertible notes 251,760 882,000  
Advance from shareholder 25,000 $ 19,500
Repayments of advance from shareholder (20,000) (19,500)
Fees associated with filing of Form S-1 (5,456)  
Net cash provided by financing activities 256,760 876,544  
Net (decrease) increase in cash 21,148 313,971  
Cash at beginning of period 11,690 8,356 8,356
Cash at end of period 32,838 322,327 $ 11,690
Cash paid during the period for:      
Interest  
Income taxes  
Non-cash investing and financing activities:      
Beneficial conversion feature in conjunction with debt issuance 303,984  
Warrants issued to third parties in conjunction with debt issuance 111,834 578,016  
Original issue discount issued in conjunction with debt 25,176 88,200  
Cancellation of common stock - related party $ 7